End-stage renal disease (ESRD) is defined as the inability of the kidneys to remove waste
products and excess fluid from the blood. ESRD progresses from earlier stages of chronic …

Background Reactive oxygen species are important mediators exerting toxic effects on
various organs during ischemia-reperfusion (IR) injury. We hypothesized that adipose …

The treatment of renal failure has changed little in decades. Organ transplantation and
dialysis continue to represent the only therapeutic options available. However, decades of …

Bone marrow–and adult kidney–derived stem/progenitor cells hold promise in the
development of therapies for renal failure. Here is reported the identification and …

This study tested whether combined therapy with melatonin and apoptotic adipose‐derived
mesenchymal stem cells (A‐ADMSC s) offered additional benefit in ameliorating sepsis …

Tissue engineering and cell therapy approaches aim to take advantage of the repopulating
ability and plasticity of multipotent stem cells to regenerate lost or diseased tissue. Recently …

Background—Understanding the mechanisms of repair and regeneration of the kidney after
injury is of great interest because there are currently no therapies that promote repair, and …

Diabetic nephropathy is the leading cause of end-stage renal disease. The aim of this study
was to investigate the renoprotective effects of autologous transplantation of adipose …

Identification of tissue‐specific renal stem/progenitor cells with nephrogenic potential is a
critical step in develo** cell‐based therapies for renal disease. In the human kidney …

In the human fetal kidney (HFK) self-renewing stem cells residing in the metanephric
mesenchyme (MM)/blastema are induced to form all cell types of the nephron till 34th week …